Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited)

v3.22.1
Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Preferred Stock [Member]
Series B Preferred Stock [Member]
Preferred Stock [Member]
Series E-1 Preferred Stock [Member]
Common Stock [Member]
Deferred Stock Based Compensation [Member]
Additional Paid-in Capital [Member]
Stock Subscription [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 49 $ (148,333) $ 11,023,738 $ (25,000) $ (15,911,895) $ (5,061,441)
Beginning balance, shares at Dec. 31, 2020 281   486,806          
Common stock issued for services, include a director $ 1 115,000 537,391 652,392
Stock-based compensation for services and warrant modification, shares     6,250          
Conversion of debentures $ 2 515,066 515,068
Conversion of debentures and accrued expenses, shares     15,825          
Conversion of bridge notes and accrued interest to common stock $ 17 4,378,471 $ 4,378,488
Conversion of bridge notes and accrued interest to common stock, shares     165,692         165,692
Conversion of Series A preferred stock to common stock $ 2 662,498 (542,500) $ 120,000
Conversion of Series A preferred stock to common stock, shares     18,750          
Series A, preferred stock contractual dividends (7,899) (7,899)
Issuance of Series B, preferred stock for cash $ 2 2,195,998 25,000 2,221,000
Issuance of Series B, preferred stock for cash, shares 2,196              
Issuance of Series B, conversion of notes payable to preferred stock 23,000 23,000
Issuance of Series B, conversion of notes payable to preferred stock, shares 23              
Accretion of stock-based compensation to employees and directors $ 1 (4,141,777) 6,527,999 2,386,223
Stock-based compensation to employees and directors, shares   850            
Net loss period   (4,406,059) (4,406,059)
Ending balance, value at Mar. 31, 2021 $ 2 $ 1 $ 71 (4,175,110) 25,856,262 (20,860,454) 820,772
Ending balance, shares at Mar. 31, 2021 2,500 8,500 693,323          
Beginning balance, value at Dec. 31, 2021 $ 2 $ 165 (900,742) 29,765,585 (29,281,674) (416,664)
Beginning balance, shares at Dec. 31, 2021 1,509   1,652,102          
Common stock issued for services, include a director $ 3 254,748 $ 254,751
Stock-based compensation for services and warrant modification, shares     28,750         18,750
Conversion of debentures     $ 1 34,999     $ 35,000
Conversion of debentures and accrued expenses, shares     5,469          
Series A, preferred stock contractual dividends (7,202) (7,202)
Accretion of stock-based compensation to employees and directors 213,041 107,312 320,353
Net loss period (1,788,246) (1,788,246)
Incremental value from warrant modifications 41,225 (41,225)
40:1 Reverse Split Fractional Shares Adjustment
40:1 Reverse Split Fractional Shares Adjustment, shares     266          
Series B, preferred stock contractual dividends (37,206) (37,206)
Ending balance, value at Mar. 31, 2022 $ 2 $ 169 $ (687,701) $ 30,159,461 $ (31,111,145) $ (1,639,214)
Ending balance, shares at Mar. 31, 2022 1,509   1,686,587